ophthalmology
Hodapp-Anderson-Parrish Visual Field Glaucoma Severity
Visual-field-based staging of glaucomatous damage (Hodapp 1993) using mean deviation (MD) on 24-2 SITA-Standard fields plus pattern of central involvement. Used to stratify follow-up frequency and treatment intensity.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Netarsudil 0.02% Eye Drops · Rho-kinase (ROCK) Inhibitor — Glaucoma
- Tafluprost 0.0015% Eye Drops · Prostaglandin Analogue — Glaucoma (Preservative-Free)
- Dorzolamide / Timolol Fixed Combination (Cosopt) · Fixed Combination Glaucoma Treatment — CAI + Beta-blocker
- Latanoprostene Bunod 0.024% Eye Drops · Nitric Oxide-donating Prostaglandin Analogue — Glaucoma
- Brimonidine / Timolol Fixed Combination · Fixed Combination Glaucoma Treatment — Alpha-2 Agonist + Beta-blocker
- Betaxolol 0.5% Eye Drops · Cardioselective Beta-1 Blocker — Glaucoma
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.